Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR-T cells are as effective as freshly infused cells

被引：0
|
作者：
Dreyzin, Alexandra [1 ]
Panch, Sandhya [2 ]
Shalabi, Haneen [3 ]
Yates, Bonnie [3 ]
Shah, Nirali [3 ]
Stroncek, David [2 ]
机构：
[1] Childrens Natl Hosp, Ctr Canc & Blood Disorders, Washington, DC USA
[2] NIH, Dept Transfus Med & Cellular Engn, Ctr Cellular Engn, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA
[3] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
13
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR T cells are as effective as freshly infused cells
    Dreyzin, Alexandra
    Panch, Sandhya R.
    Shalabi, Haneen
    Yates, Bonnie
    Highfill, Steven L.
    Jin, Ping
    Stroncek, David
    Shah, Nirali N.
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2023, 28 : 51 - 61
  • [2] Anti-CD22 CAR T cells in ALL
    Killock, David
    NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (07) : 391 - 391
  • [3] Anti-CD22 CAR T cells in ALL
    David Killock
    Nature Reviews Clinical Oncology, 2020, 17 : 391 - 391
  • [4] Effect of CD22-directed CAR-T cells secreting anti-CD19 T cell engagers on control of leukemia progression compared to tandem anti-CD19/CD22 CAR-T cells.
    Arroyo-Rodenas, Javier
    Diez-Alonso, Laura
    Falgas, Aida
    Martinez-Moreno, Alba
    Gil-Etayo, Francisco Javier
    Aguilar-Sopena, Oscar
    Velasco-Sidro, Miriam
    Bravo-Martin, Clara
    Ramirez-Fernandez, Angel
    Jimenez-Reinoso, Anais
    Blanco, Belen
    Roda-Navarro, Pedro
    Bueno, Clara
    Menendez, Pablo
    Alvarez-Vallina, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Anti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapy
    Zhu, Haibo
    Deng, Haobin
    Mu, Juan
    Lyu, Cuicui
    Jiang, Yanyu
    Deng, Qi
    ONCOTARGETS AND THERAPY, 2021, 14 : 4023 - 4037
  • [6] Treatment of SLE with anti-CD19 CAR-T cells
    Ellen F. Carney
    Nature Reviews Nephrology, 2022, 18 : 743 - 743
  • [7] Treatment of SLE with anti-CD19 CAR-T cells
    Carney, Ellen F.
    NATURE REVIEWS NEPHROLOGY, 2022, 18 (12) : 743 - 743
  • [8] Characterization of Short Production Cycle and Non-Genotoxic mRNA-Based Anti-CD19 and Anti-CD22 CAR-T
    Zhang, Chenyun
    Liu, Haizhou
    Sangani, Hrithik
    Hsu, Yen-Michael S.
    MOLECULAR THERAPY, 2024, 32 (04) : 624 - 625
  • [9] Anti-CD19 CAR T-cells
    Smith, Lan-Lan
    LANCET ONCOLOGY, 2017, 18 (01): : 26 - 26
  • [10] Breaking PD-11-mediated Resistance in anti-CD19 and anti-CD22 Car T Cells with PD-1/CD28 Fusion Receptors
    Blaeschke, Franziska
    Apfelbeck, Antonia
    Stenger, Dana
    Mahdawi, Jasmin
    Lepenies, Mareike
    Rataj, Felicitas
    Willier, Semjon
    Kaeuferle, Theresa
    Gruenewald, Thomas G. P.
    Majzner, Robbie G.
    Busch, Dirk H.
    Kobold, Sebastian
    Feuchtinger, Tobias
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 258 - 259
12345